Multiple myeloma

Products
Showing all 5 results
BLENREP (belantamab mafodotin-blmf) for injection
BLENREP (belantamab mafodotin-blmf) for injection, for intravenous use. Initial U.S. Approval: 2020
DARZALEX (daratumumab) injection
DARZALEX (daratumumab) injection, for intravenous use. Initial U.S. Approval – 2015
NINLARO ® (ixazomib) capsules, for oral use
NINLARO (ixazomib) capsules, for oral use. Initial U.S. Approval: 2015
POMALYST ® (pomalidomide) capsules
POMALYST (pomalidomide) capsules, for oral use. Initial US Approval: 2013
REVLIMID [lenalidomide] capsules
REVLIMID [lenalidomide] capsules, for oral use. Initial US Approval: 2005